Author: Healio ophthalmology

Gobiquity receives $6 million in funding for pediatric vision screening program

Gobiquity Mobile Health received $6 million in Series B financing from venture capital firm InterWest Partners to support the company’s pediatric vision screening program.The company announced in a press release that more than 100,000 children have been screened with GoCheck Kids, its flagship product. More than 3,000 children are being screened weekly, signifying more than 300% annual growth.

High drug prices result of government protection in US

The high cost of prescription drugs in the United States is the result of drug manufacturers being granted government-protected monopolies, according to data published in JAMA Internal Medicine.“The increasing cost of prescription drugs in the United States has become a source of growing concern for patients, prescribers, payers and policy makers,” Aaron S. Kesselheim, MD, JD, MPH, of the department of medicine at Brigham and Women’s Hospital and Harvard Medical School, and colleagues wrote. “In addition to their contribution to health care spending, increasing drug costs have important clinical implications. (Read more...)

Stegmann canal expander helps lower IOP in patients with primary open-angle glaucoma

The Stegmann canal expander, implanted during canaloplasty, lowered IOP and reduced complications in patients with primary open-angle glaucoma, according to a study. The prospective, single-center noncomparative study included 22 eyes of 22 consecutive patients with medically uncontrolled primary open-angle glaucoma who underwent primary viscocanalostomy and implantation of the new canal expander. The expander was implanted into Schlemm’s canal, and patient follow-up time was at least 1 year.

Publication Exclusive: Surgeons detail steps for simple limbal epithelial transplantation

In 1964, Jose Barraquer described a surgical technique for limbal stem cell deficiency, or LSCD. The paramount finding of extensive LSCD is conjunctival transgression across the corneal-conjunctival border and the limbus and onto the cornea, resulting in vascularization, chronic inflammation, persistent epithelial defects and recurrent erosions, which uninterrupted can progress to corneal opacity and transform to a skin-like corneal surface with corneal blindness. These border “policemen” between the corneal and conjunctival territories are largely accepted as the limbal stem cells that are believed to be housed within the radial fibrovascular (Read more...)

Application of whole blood before staining improves outcomes of macular hole surgery

Application of whole blood followed by brilliant blue staining of the internal limiting membrane allowed earlier and better visual rehabilitation in macular hole surgery than conventional brilliant blue staining, a study found.“[This] could be attributed to earlier photoreceptor regeneration as evidenced by inner segment/outer segment junction continuity and increase in outer foveal thickness,” the study authors, from Guru Nanak Eye Centre in New Delhi, India, said.

Publication Exclusive: Good early results seen with pre-Descemet’s endothelial keratoplasty in failed grafts

Graft failure in any situation can happen due to inherent defects in the donor graft or pre-existing pathology in the recipient. Inherent graft issues such as low endothelial cell count, surgical trauma to the graft and endothelial disease in the donor can cause early graft failure. Graft rejection is another main etiology that can happen, especially in full-thickness keratoplasty. Lamellar keratoplasty procedures have been shown to have fewer incidences of rejection, but rejection has been noticed after deep lamellar keratoplasty. The corneal stroma is the culprit often recognized as the (Read more...)